Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

How digital pathology can help drug developers address the forked road in oncology and beyond

By Author Proscia | April 9, 2024

Editor Brian Buntz summaries a recent webinar presented by Nathan Buchbinder, our Chief Strategy Officer; Dr. John Cochran, Chief Medical Officer and Chief Pathologist at Q² Solutions; and Dr. Monika Lamba Saini, Pathologist-Scientist and Director of Digital Innovation at Q² Solutions.

Our website uses cookies. By using this site, you agree to its use of cookies.